Enveric Biosciences (ENVB) Stock Chart & Stock Price History → IRS Loophole Gives Americans An Escape From Inflation (From Birch Gold) (Ad) Free ENVB Stock Alerts $0.96 +0.08 (+8.78%) (As of 10:06 AM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Enveric Biosciences Stock Price Performance5 Day Performance-5.01%1 Month Performance-12.78%3 Month Performance-10.34%6 Month Performance-53.43%Year-To-Date Performance-26.20%1 Year Performance-42.89% Receive ENVB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Enveric Biosciences and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Birch GoldIRS Loophole Gives Americans An Escape From InflationIn the years immediately following 2008-09, as the economy stagnated, gold exploded in value. Today, Goldman Sachs is telling its clients that gold may reach $2,250 within the next few years. Don't miss your chance to diversify your savings.Request your info kit on gold now ENVB Stock Chart for Thursday, April, 18, 2024 ENVB Chart by TradingView Enveric Biosciences Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/17/2024$0.91$0.88-3.18%$0.96$0.8881,992 shs$6.43 million04/16/2024$0.92$0.91-1.14%$0.95$0.89114,527 shs$6.64 million04/15/2024$1.01$0.92-8.76%$1.03$0.91165,141 shs$6.72 million04/12/2024$0.91$1.01+10.95%$1.03$0.92382,892 shs$7.36 million04/11/2024$0.93$0.91-1.93%$0.95$0.9061,623 shs$6.64 million04/10/2024$0.94$0.93-1.38%$0.95$0.8947,882 shs$6.77 million Get the Latest News and Ratings for ENVB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enveric Biosciences and its competitors with MarketBeat's FREE daily newsletter. 04/09/2024$0.92$0.94+2.29%$0.99$0.90108,215 shs$6.86 million04/08/2024$0.93$0.92-1.06%$0.96$0.9187,380 shs$6.71 million04/05/2024$0.95$0.93-2.21%$0.99$0.8989,892 shs$5.02 million04/04/2024$1.01$0.95-5.84%$1.00$0.95154,153 shs$5.14 million04/03/2024$1.14$1.01-11.40%$1.05$0.89599,957 shs$5.45 million04/02/2024$0.89$1.14+28.09%$1.19$0.831.55 million shs$6.16 million04/01/2024$1.00$0.89-11.00%$1.00$0.88454,398 shs$4.81 million03/29/2024$1.00$1.00$1.04$1.00268,386 shs$5.40 million03/28/2024$1.02$1.00-1.96%$1.04$1.00266,677 shs$5.40 million03/27/2024$1.06$1.02-3.77%$1.04$1.00384,787 shs$5.51 million03/26/2024$1.05$1.06+0.95%$1.08$1.02304,540 shs$5.72 million03/25/2024$1.13$1.05-7.08%$1.16$1.03443,641 shs$5.67 million03/22/2024$1.17$1.13-3.42%$1.20$1.11294,045 shs$6.10 million03/21/2024$1.17$1.17$1.23$1.10833,356 shs$6.32 million03/20/2024$1.19$1.17-1.68%$1.27$1.082.42 million shs$6.32 million03/19/2024$1.10$1.19+8.18%$1.87$1.1151.85 million shs$6.43 million03/18/2024$1.08$1.10+1.85%$1.12$1.06139,393 shs$5.94 million03/15/2024$1.10$1.08-1.82%$1.15$1.08124,865 shs$2.96 million03/14/2024$1.16$1.10-5.17%$1.10$1.05213,173 shs$3.01 million03/13/2024$1.20$1.16-3.33%$1.23$1.01293,402 shs$3.18 million03/12/2024$1.32$1.20-9.09%$1.37$1.14636,219 shs$3.29 million03/11/2024$1.41$1.32-6.38%$1.51$1.28291,120 shs$3.62 million03/08/2024$1.52$1.41-7.24%$1.56$1.40268,665 shs$3.86 million03/07/2024$1.38$1.52+10.14%$1.63$1.28602,556 shs$4.17 million03/06/2024$1.41$1.38-2.13%$1.45$1.25554,119 shs$3.78 million03/05/2024$1.55$1.41-9.03%$1.55$1.40657,586 shs$3.86 million03/04/2024$1.66$1.55-6.63%$1.60$1.401.39 million shs$4.25 million03/01/2024$1.45$1.66+14.48%$1.90$1.4513.64 million shs$4.55 million02/29/2024$0.83$1.45+74.49%$2.92$1.32176.77 million shs$3.97 million02/28/2024$0.84$0.83-1.07%$0.90$0.8376,985 shs$2.28 million02/27/2024$0.85$0.84-1.34%$0.95$0.81273,556 shs$2.30 million02/26/2024$0.98$0.85-13.12%$0.95$0.84478,063 shs$2.33 million02/23/2024$0.86$0.98+14.09%$1.27$0.9313.21 million shs$2.69 million02/22/2024$0.86$0.86+0.23%$0.89$0.8426,926 shs$2.35 millionIRS Loophole Gives Americans An Escape From Inflation (Ad)In the years immediately following 2008-09, as the economy stagnated, gold exploded in value. Today, Goldman Sachs is telling its clients that gold may reach $2,250 within the next few years. Don't miss your chance to diversify your savings.Request your info kit on gold now02/21/2024$0.87$0.86-1.03%$0.91$0.83103,286 shs$2.35 million02/20/2024$0.83$0.87+4.20%$0.89$0.8063,376 shs$2.37 million02/19/2024$0.83$0.83$0.84$0.808,400 shs$2.28 million02/16/2024$0.84$0.82-2.01%$0.84$0.817,247 shs$2.25 million02/15/2024$0.82$0.84+1.71%$0.84$0.8126,303 shs$2.30 million02/14/2024$0.82$0.82+1.21%$0.83$0.7814,397 shs$2.26 million02/13/2024$0.81$0.82+0.74%$0.82$0.7818,480 shs$2.23 million02/12/2024$0.77$0.81+5.02%$0.84$0.7798,110 shs$2.22 million02/09/2024$0.81$0.77-5.10%$0.85$0.7733,009 shs$2.11 million02/08/2024$0.82$0.81-0.69%$0.83$0.7734,523 shs$2.22 million02/07/2024$0.85$0.82-3.37%$0.83$0.76140,196 shs$2.24 million02/06/2024$0.85$0.85-0.62%$1.14$0.791.24 million shs$2.32 million02/05/2024$0.87$0.85-1.89%$0.87$0.8016,802 shs$2.33 million02/02/2024$0.90$0.85-5.79%$0.90$0.7589,137 shs$2.33 million02/01/2024$0.74$0.90+22.71%$0.96$0.65476,590 shs$2.48 million01/31/2024$0.80$0.74-7.98%$0.81$0.71128,714 shs$2.02 million01/30/2024$0.89$0.80-10.05%$0.94$0.791.52 million shs$2.19 million01/29/2024$0.90$0.89-0.90%$0.93$0.8730,997 shs$2.44 million01/26/2024$0.88$0.90+1.70%$0.93$0.8763,449 shs$2.46 million01/25/2024$0.88$0.88+0.28%$0.90$0.8727,385 shs$2.42 million01/24/2024$0.93$0.88-5.84%$0.93$0.8730,284 shs$2.41 million01/23/2024$1.01$0.93-7.47%$1.01$0.8555,416 shs$2.56 million01/22/2024$1.09$1.01-7.34%$1.15$0.9979,319 shs$2.77 million01/19/2024$1.07$1.10+2.80%$1.12$1.0618,792 shs$3.01 million01/18/2024$1.12$1.07-4.46%$1.10$1.066,891 shs$2.93 million01/17/2024$1.23$1.12-8.94%$1.22$1.0639,060 shs$3.07 million Related Companies: SHPH Stock Price Chart SBFM Stock Price Chart UPC Stock Price Chart IBIO Stock Price Chart HILS Stock Price Chart GRAY Stock Price Chart ADXS Stock Price Chart AIMD Stock Price Chart CVKD Stock Price Chart TENX Stock Price Chart Receive ENVB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Enveric Biosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ENVB) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority Gold[Urgent!] Generational Wealth GameplanCrypto 101 MediaIRS Loophole Gives Americans An Escape From InflationBirch GoldThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsThe “Perfect Storm” for GoldGold Safe ExchangeThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enveric Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.